Exos TFP Holdings’s Ibere Pharmaceuticals IBER Stock Holding History

Exos TFP Holdings’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,792	Closed	-$230K	–	573
2022 Q4	$230K	Buy	+22,792	New	+$228K	0.06%	237

Exos TFP Holdings's IBER Position: Q1 2023 in Review

Exos TFP Holdings sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 22,792 shares — an estimated $230K sold.

Exos TFP Holdings first reported a position in IBER in Q4 2022 and held it in 1 quarter. The position peaked at $230K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Exos TFP Holdings reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Exos TFP Holdings sold 22,792 Ibere Pharmaceuticals shares in Q1 2023, an estimated $230K.
Exos TFP Holdings first reported a position in Ibere Pharmaceuticals in Q4 2022 and held it in 1 quarter.
Exos TFP Holdings's Ibere Pharmaceuticals position peaked at $230K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.